Alzheimer Aβ Vaccination of Rhesus Monkeys (Macaca Mulatta)
- 1 January 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 18 (1) , 44-46
- https://doi.org/10.1097/00002093-200401000-00009
Abstract
Recent preliminary data suggest that vaccination with Alzheimer Aβ might reduce senile plaque load and stabilize cognitive decline in human Alzheimer disease. To examine the mechanisms and consequences of anti-Aβ-antibody formation in a species more closely related to humans, rhesus monkeys (Macaca mulatta) were vaccinated with aggregated Aβ1-42. Immunized monkeys developed anti-Aβ titers exceeding 1:1000, and their plasma Aβ levels were 5- to 10-fold higher than the plasma Aβ levels observed in monkeys vaccinated with aggregated amylin. These data support the use of nonhuman primates to model certain phenomena associated with vaccination of humans with aggregated Alzheimer Aβ.Keywords
This publication has 4 references indexed in Scilit:
- Effect of Different Anti-Aβ Antibodies on Aβ Fibrillogenesis as Assessed by Atomic Force MicroscopyJournal of Molecular Biology, 2003
- Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's DiseaseNeuron, 2003
- Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2001
- Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's diseaseNature, 2000